This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
March 7, 2013 /PRNewswire/ -- A collaborative group of academic research organizations is revolutionizing the way clinical research is conducted through their participation in the Research Resonance Network. The network's host, Forte Research Systems, Inc., has announced the availability of a new online home for the group along with a suite of tools for improving clinical research processes. Registration is now open to access the first resource to go live on the network, the Site Metrics Registry. This registry is the culmination of seven years of effort driven, in large part, by 20 leading academic medical centers including the Yale Center for Clinical Investigation and
Indiana University Simon Cancer Center.
There is a growing interest in improving the processes around clinical study execution. Most stakeholders in the drug development industry agree that the current environment is not sustainable. Similarly, the National Cancer Institute and the National Center for Advancing Translational Sciences have undertaken major efforts for process improvement as they seek avenues for speeding up the development of new therapies.
"A cursory glance at the current drug development landscape reveals ever-increasing unhealthy trends. Protocols are getting more complicated, study startup is labor intensive and inefficient, and centers face challenges in everything from compliance to financial viability," said Srini Kalluri, Forte's founder, president, CEO and Chief Customer Officer. "By allowing centers to share, compare, and take action based on their data, the Research Resonance Network helps centers work together to find better solutions."
The desire for improvement is evident in such initiatives as TransCelerate BioPharma, Inc., the Clinical Trials Transformation Initiative (CTTI), and the Alliance for Clinical Research Excellence and Safety (ACRES), all of which strive to bring key stakeholders together to find ways to improve clinical research.
Under the leadership provided by the participating centers, the Research Resonance Network Site Metrics Registry, hosted at
www.ResearchResonance.net, is already delivering value with its library of standard data definitions for a large number of performance measurements, also referred to as "metrics." The registry contains metrics for: evaluating cycle times in such areas as IRB approval and contracting; measuring the size of clinical research operations in such areas as the number of open protocols and new subject accruals; and measuring effort in areas that include data management and budgeting.
"We've taken the initiative to work with Forte on this effort because we believe it's an invaluable tool for academic medical centers and Clinical and Translational Science Award (CTSA) sites. Knowing how our peer institutions are doing helps us to improve our own clinical research processes and timelines," said
Robert Sherwin, MD, CNH, Long Professor of Medicine at the
Yale School of Medicine and director of the Yale Center of Clinical Investigation.
Using sophisticated security mechanisms, the registry allows centers to contribute their data and then compare their own performance to anonymous data aggregated from their peers. Forte acts as the trusted third party ensuring that the privacy of all participants is protected and nothing is ever shared with unauthorized individuals or in any way that allows the participating centers to be identified.